These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
483 related articles for article (PubMed ID: 34887218)
1. A descriptive study of inflammatory bowel disease at an Egyptian tertiary care center. El-Atrebi KA; Taher E; El Aguizy FH; Ali RM; Hegazy A; El-Sayed MM; Eysa B; El-Atreby AA; Mohammed AA; El-Bassyouni HT Rev Gastroenterol Mex (Engl Ed); 2023; 88(1):12-18. PubMed ID: 34887218 [TBL] [Abstract][Full Text] [Related]
2. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt. Esmat S; El Nady M; Elfekki M; Elsherif Y; Naga M World J Gastroenterol; 2014 Jan; 20(3):814-21. PubMed ID: 24574754 [TBL] [Abstract][Full Text] [Related]
3. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969 [TBL] [Abstract][Full Text] [Related]
5. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients. Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817 [TBL] [Abstract][Full Text] [Related]
6. Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study. D'Amico F; Gomollón F; Bamias G; Magro F; Targownik L; Leitner C; Heatta-Speicher T; Michelena N; Kolterer S; Lapthorn J; Kauffman L; Dignass A; United European Gastroenterol J; 2024 Jul; 12(6):705-716. PubMed ID: 38733307 [TBL] [Abstract][Full Text] [Related]
7. Clinical and therapeutic characterisation of a multicentre cohort of patients with inflammatory bowel disease in Colombia. Parra-Izquierdo V; Flórez Sarmiento C; Frías-Ordoñez JS; Vargas M; Kock J; Lozano Escobar N; Márquez JR Gastroenterol Hepatol; 2023 Oct; 46(8):585-593. PubMed ID: 36464080 [TBL] [Abstract][Full Text] [Related]
8. Incidence, and natural history of inflammatory bowel disease in Castilla y León: Prospective and multicenter epidemiological study. Sáiz-Chumillas RM; Barrio J; Fernández-Salazar L; Arias L; Sierra Ausín M; Piñero C; Fuentes Coronel A; Mata L; Vásquez M; Carbajo A; Alcaide N; Cano N; Nuñez A; Fradejas P; Ibáñez M; Hernández L; Sicilia B Gastroenterol Hepatol; 2023 Feb; 46(2):102-108. PubMed ID: 35569540 [TBL] [Abstract][Full Text] [Related]
9. Association of fatigue with disease activity and clinical manifestations in patients with Crohn's disease and ulcerative colitis: an observational cross-sectional study in the United States. Gibble TH; Shan M; Zhou X; Naegeli AN; Dubey S; Lewis JD Curr Med Res Opin; 2024 Sep; 40(9):1537-1544. PubMed ID: 39037798 [TBL] [Abstract][Full Text] [Related]
10. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study. Balderramo D; Yamamoto-Furusho J; Ponce de León E; de María J; Zubiaurre I; Pedreira S; Lis C; Brion L; de Paula JA Gastroenterol Hepatol; 2024 Jan; 47(1):51-62. PubMed ID: 37062500 [TBL] [Abstract][Full Text] [Related]
11. Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn's Disease in Italy. Dovizio M; Hartz S; Buzzoni C; Redondo I; Nedeljkovic Protic M; Birra D; Perrone V; Veronesi C; Degli Esposti L; Armuzzi A Adv Ther; 2024 Jun; 41(6):2282-2298. PubMed ID: 38619721 [TBL] [Abstract][Full Text] [Related]
13. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil. Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478 [TBL] [Abstract][Full Text] [Related]
14. Risk Factors for the Occurrence and Severity of Vertebral Fractures in Inflammatory Bowel Disease Patients: A Nationwide Population-Based Cohort Study. Choi A; Jung SH; Kim S; Lee JS J Korean Med Sci; 2023 Jul; 38(28):e210. PubMed ID: 37463684 [TBL] [Abstract][Full Text] [Related]
15. Association between inflammatory bowel disease and subsequent depression or anxiety disorders - A retrospective cohort study of 31,728 outpatients. Roderburg C; Yaqubi K; Konrad M; May P; Luedde T; Kostev K; Loosen SH J Psychiatr Res; 2024 Jan; 169():231-237. PubMed ID: 38048672 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation. Yamamoto-Furusho JK; Bosques-Padilla F; de-Paula J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Rocha JL; Steinwurz F; Veitia G; Zaltman C Rev Gastroenterol Mex; 2017; 82(1):46-84. PubMed ID: 27979414 [TBL] [Abstract][Full Text] [Related]
17. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423 [TBL] [Abstract][Full Text] [Related]
18. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study. Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047 [TBL] [Abstract][Full Text] [Related]
19. Spectrum and trend of pediatric inflammatory bowel disease: A two-decade experience from northern India. Mohan N; Deswal S; Bhardwaj A Indian J Gastroenterol; 2024 Feb; 43(1):208-214. PubMed ID: 37943479 [TBL] [Abstract][Full Text] [Related]
20. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium. Banerjee R; Pal P; Hilmi I; Ghoshal UC; Desai DC; Rahman MM; Dutta U; Mohiuddin SA; Al Mohannadi M; Philip M; Ramesh GN; Niriella MA; De Silva AP; de Silva HJ; Pisespongsa P; Limsrivilai J; Aniwan S; Nawarathne M; Fernandopulle N; Aye TT; Ni N; Al Awadhi S; Joshi N; Ngoc PTV; Kieu TV; Nguyen AD; Abdullah M; Ali E; Zeid A; Sollano JD; Saberi B; Omar M; Mohsin MN; Aftab H; Wai TM; Shastri YM; Chaudhuri S; Ahmed F; Bhatia SJ; Travis SPL; J Gastroenterol Hepatol; 2022 Jun; 37(6):1004-1015. PubMed ID: 35178742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]